Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012-Reference-Cited by-同舟云学术

Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012

Published:2015-01-25 Issue:3 Volume:25 Page:350-357
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Sato Eri,Tanaka Eiichi,Ochiai Moeko,Shimizu Yoko,Kobayashi Akiko,Shidara Kumi,Hoshi Daisuke,Sugimoto Naoki,Inoue Eisuke,Seto Yohei,Nakajima Ayako,Taniguchi Atsuo,Momohara Shigeki,Yamanaka Hisashi

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/14397595.2014.958274

Reference45 articles.

1. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

2. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

4. Treating rheumatoid arthritis to target: recommendations of an international task force

5. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease–modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data;Modern Rheumatology;2023-07-06

2. The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study;Rheumatology International;2022-01-29

3. Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study;Modern Rheumatology;2021-12-15

4. Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics;Modern Rheumatology;2021-09-10

5. Differences in patients’ population and efficacy/effectiveness of biologic disease–modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis – using the IORRA cohort;Modern Rheumatology;2021-09-10